Safety
Safety information
Your safety comes first. Review important information about the treatments available through the platform before you begin, and always follow the guidance of your prescribing provider.
Boxed warnings
Compounded Semaglutide (GLP-1)
Boxed warning — risk of thyroid C-cell tumors. In rodent studies, semaglutide caused thyroid C-cell tumors. It is not known whether it causes such tumors, including medullary thyroid carcinoma (MTC), in humans. Do not use if you or a family member have had MTC or have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Read full safety information →Compounded Tirzepatide (GLP-1/GIP)
Boxed warning — risk of thyroid C-cell tumors. In rodent studies, tirzepatide caused thyroid C-cell tumors. It is not known whether it causes such tumors, including medullary thyroid carcinoma (MTC), in humans. Do not use if you or a family member have had MTC or have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Read full safety information →Safety by compound
Completing an assessment on this site does not create a doctor-patient relationship and does not guarantee treatment. Diadara is not a healthcare provider; it is a technology platform that connects you with independent licensed providers and pharmacies. Treatment is only provided when prescribed by a licensed provider. Compounded medications are prepared by licensed US pharmacies on a valid prescription and are not reviewed or approved by the FDA for safety or effectiveness.
This page is general educational information, not medical advice, and is not a complete list of risks. Your prescribing provider will review your full history. Report side effects to your provider; you may also report to the FDA at 1-800-FDA-1088.